HYPE short wipes out trader’s $42M gains
An onchain trader known as loracle.hl erased $42.2 million in profits accumulated over nearly 10 months after a leveraged short position against HYPE moved sharply against them.
An onchain trader known as loracle.hl erased $42.2 million in profits accumulated over nearly 10 months after a leveraged short position against HYPE moved sharply against them.
People Incorporated, the digital media and internet conglomerate formerly known as IAC (NASDAQ:IAC), announced Monday that it has submitted a non-binding proposal to the Board of Directors of MGM Resorts International (NYSE:MGM) to acquire all of the outstanding shares of the hospitality giant it does not currently own.
Software giant Microsoft (NASDAQ:MSFT) and computer hardware manufacturers Dell Technologies (NYSE:DELL) and HP (NYSE:HPE) saw their shares rise in premarket trading on Monday morning following a major market expansion announcement from artificial intelligence chip heavyweight Nvidia (NASDAQ:NVDA).
KuCoin has launched its KuCard payment product in Australia, allowing eligible users to spend supported digital assets at merchants that accept Mastercard.
Crypto trading firm Wintermute has expanded into prediction markets, aiming to provide liquidity across event-based contracts as the sector experiences rapid growth.
Yum Brands (NYSE:YUM) is in exclusive negotiations to sell its Pizza Hut chain to private equity firm LongRange Capital, according to sources familiar with the matter.
US Senator Cynthia Lummis has warned that Congress could miss a critical opportunity to establish comprehensive cryptocurrency legislation, potentially delaying major regulatory reforms until 2030.
Greenwich LifeSciences (NASDAQ:GLSI) reported new open-label immune response data from its ongoing Phase III FLAMINGO-01 clinical trial evaluating its lead immunotherapy candidate, GLSI-100, in patients with HER2-positive breast cancer.
An Ethereum developer has argued that ether’s 65% decline against Bitcoin since the network’s 2022 Merge reflects years of execution failures rather than broader market conditions or coordination challenges.
Rallybio (NASDAQ:RLYB) and Avenzo Therapeutics announced Monday that they have entered into a definitive agreement to combine through a merger transaction.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas